Market News
Smart Trading. Simplified.
Why a "Tech Wreck" may have just begun..
They called the 2020 crash 45 days early. Nobody expects what they're predicting now...
Sponsored
Is CrowdStrike Stock A Buy?
Is CrowdStrike Stock A Buy? If CrowdStrike share price were a stallion, it would be headed to the Kentucky Derby or the Belmont Stakes. The company resoundingly rebounded from a reality check in the fall of 2019. Share prices soared by over 120%. And the company’s revenue nearly doubled since then. CrowdStrike is nearing $800 […]
Small Biotech Firm Stuns World
On November 16, 2016 a small biotech used a radical new treatment to restore blindness in mice. CBS News called this breakthrough "the most consequential discovery in biomedicine this century."
Investors who get in early are set to earn 46,751% returns.
Sponsored
3 Best Stocks For Year End
The divisive 2020 election is over, and the coronavirus pandemic is now part of daily life. You (and your portfolio) have seen the biggest stock market crash in our generation. Some stocks that seemed like sure bets in 2019 (airlines, healthcare, retail, etc.) turned toxic, while others (Amazon, Microsoft, Zoom, etc) skyrocketed to historic high […]
Ignore 335 days out of the year... and still 100X your money?
Ignore 335 days out of the year every year you could trade Adobe precisely on December 20th and every year reap a 106.99% average return?
And it worked for an entire decade... Producing winner, after winner, and giving you over 100X total return on your money.
Turns out Adobe's not the only stock... there's dozens more.
Click here to uncover the secret "Wall Street calendar" for free
Sponsored
Verizon Stock Vs. T-Mobile: Which Is Best?
Verizon Stock Vs. T-Mobile: Marketers dream of creating campaigns so successful that their taglines are woven into popular culture. Got Milk? (California Milk Processor Board), Just do it (Nike), and Where’s the Beef? (Wendy’s) are iconic. Verizon had its own moment of marketing magic with television ads that ran from 2002 to 2011. The tagline […]
New 5G "Arrow" to Replace Nuclear Missiles
On August 30, 2019, a small firm won a contract from the Pentagon to build a strange new weapon. The New York Times reports "No existing defense can stop it." This under-the-radar company is not yet a household name.
Our research proves that anyone who gets in now could turn $1,000 into $461,800 >>>
Sponsored
Is Pfizer A Good Dividend Stock?
Pfizer Inc. (NYSE:PFE) is a long-standing American pharmaceutical company that was founded all the way back in 1849 by Charles Pfizer and Charles F. Erhart. It since grew to become a global enterprise and one of the largest drug companies in the world. It’s a component of both the S&P 100 and S&P 500 and […]
America's Boldest Financial Experiment Yet!
Live from the crazy streets of California - America's boldest financial experiment yet! Financial genius reveals how to buy...
Sponsored
Is Herman Miller Stock A Buy?
Herman Miller, Inc. (NASDAQ:MLHR) is a Michigan furniture company that specializes in office furniture and equipment (although it does home designs too). The company found itself in a great position during the coronavirus pandemic, as people across the world scrambled to set up home offices to remain productive. Sales held up much better than expected, […]
SELL Your Marijuana Stocks Today... Buy This "Pot Biotech" Instead
A breakthrough discovery is about to catapult one neglected biotech to the top of the marijuana industry. With 56 cannabis drug patents... this company could turn every $1,000 stake into $61,770. But you need to take action before an upcoming Senate vote turns the company into a household name.
Sponsored
View this email online if it doesn't display correctly. This newsletter is not financial advice. Please read our Disclaimer.
To unsubscribe from Financhill, click here.
Financhill is not an investment advisor and is not registered with the U.S. Securities and Exchange Commission or the Financial Industry Regulatory Authority. Further, owners, employees, agents or representatives of Financhill are not acting as investment advisors and might not be registered with the U.S. Securities and Exchange Commission or the Financial Industry Regulatory.
The sender of this email makes no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended in this email, and makes no representations or warranties concerning said company or entity's compliance with applicable laws and regulations, including, but not limited to, regulations promulgated by the SEC or the CFTC. The sender of this email may receive a portion of the proceeds from the sale of any products or services offered by a company or entity mentioned or recommended in this email. The recipient of this email assumes responsibility for conducting its own due diligence on the aforementioned company or entity and assumes full responsibility, and releases the sender from liability, for any purchase or order made from any company or entity mentioned or recommended in this email.
The content on any of Financhill websites, products or communication is for educational purposes only. Nothing in its products, services, or communications shall be construed as a solicitation and/or recommendation to buy or sell a security. Trading stocks, options and other securities involves risk. The risk of loss in trading securities can be substantial. The risk involved with trading stocks, options and other securities is not suitable for all investors. Prior to buying or selling an option, an investor must evaluate his/her own personal financial situation and consider all relevant risk factors. See: Characteristics and Risks of Standardized Options. The Financhill.com educational training program and software services are provided to improve financial understanding.
The information presented in this site is not intended to be used as the sole basis of any investment decisions, nor should it be construed as advice designed to meet the investment needs of any particular investor. Nothing in our research constitutes legal, accounting or tax advice or individually tailored investment advice. Our research is prepared for general circulation and has been prepared without regard to the individual financial circumstances and objectives of persons who receive or obtain access to it. Our research is based on sources that we believe to be reliable. However, we do not make any representation or warranty, expressed or implied, as to the accuracy of our research, the completeness, or correctness or make any guarantee or other promise as to any results that may be obtained from using our research. To the maximum extent permitted by law, neither we, any of our affiliates, nor any other person, shall have any liability whatsoever to any person for any loss or expense, whether direct, indirect, consequential, incidental or otherwise, arising from or relating in any way to any use of or reliance on our research or the information contained therein. Some discussions contain forward looking statements which are based on current expectations and differences can be expected. All of our research, including the estimates, opinions and information contained therein, reflects our judgment as of the publication or other dissemination date of the research and is subject to change without notice. Further, we expressly disclaim any responsibility to update such research. Investing involves substantial risk. Past performance is not a guarantee of future results, and a loss of original capital may occur. No one receiving or accessing our research should make any investment decision without first consulting his or her own personal financial advisor and conducting his or her own research and due diligence, including carefully reviewing any applicable prospectuses, press releases, reports and other public filings of the issuer of any securities being considered. None of the information presented should be construed as an offer to sell or buy any particular security. As always, use your best judgment when investing.
Past performance is no guarantee of future performance. This product is for educational purposes only. Practical application of the products herein are at your own risk and Financhill.com, its partners, representatives and employees assume no responsibility or liability for any use or mis-use of the product. Please contact your financial advisor for specific financial advice tailored to your personal circumstances. Any trades shown are hypothetical example and do not represent actual trades. Actual results may differ. Nothing here in constitutes a recommendation respecting the particular security illustrated.
No comments:
Post a Comment